Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - spironolactone -

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - atropine sulfate; diphenoxylate hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - lomefloxacin hydrochloride, quantity: 441.6 mg - tablet, film coated - excipient ingredients: lactose monohydrate; carmellose calcium; magnesium stearate; hyprolose; peg-40 stearate; hypromellose; macrogol 400; purified water; ethanol; titanium dioxide; methanol - treatment of uncomplicated urinary tract infections. treatment of complicated including recurrent urinary tract infections. treatment of acute exacerbation of chronic bronchitis. in the prophylactic treatment of postoperative urinary tract infections in patients undergoing transurethral surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - spironolactone, quantity: 25 mg; butizide, quantity: 2.5 mg - tablet - excipient ingredients: calcium sulfate dihydrate; maize starch; povidone; magnesium stearate; fragrance (perfume) - indications for thailand only: the treatment of essential hypertension; oedema and ascites of congestive heart failure, cirrhosis of the liver, the nephrotic syndrome and idiopathic oedema. aldosterone may be an aetiologic factor in some cases involving maliganant effusions and beneficial results have been reported with the use of spironolactone-thiazide combinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - spironolactone, quantity: 25 mg; butizide, quantity: 2.5 mg - tablet - excipient ingredients: calcium sulfate dihydrate; maize starch; povidone; magnesium stearate; flavour

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - psyllium hydrophilic mucilloid, quantity: 312.8 mg/g - powder - excipient ingredients: sucrose; flavour

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - psyllium hydrophilic mucilloid, quantity: 0.56 g/g - powder, oral - excipient ingredients: sodium bicarbonate; sucrose; saccharin sodium; potassium bicarbonate; sunset yellow fcf; flavour - indications for: malaysia and singapore metamucil is indicated in the management of chronic constipations, constipation in irritable bowel syndrome, as adjunctive therapy in diverticulr disease and constipation caused by antacid use in duodenal ulcer; in the bowel management of patients with haemorroids, and for constipation during pregnancy, convalescence and senility

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - disopyramide phosphate, quantity: 193.2 mg - tablet - excipient ingredients: hard paraffin; polyvinyl acetate; magnesium stearate; hypromellose; macrogol 6000; titanium dioxide - indications for: new zealand and thailand,norpace is indicated for the treatment and prevention of recurrence of the following cardiac arrhythmias when they occur singly or in combination. premature atrial contractions. paroxysmal supraventricular tachycardia, including that associated with the wolf-parkinson- white syndrome. maintenance of normal sinus rythm following electroconversion of atrial flutter or atrial fibrillation. premature ventricular contractions-whether unifocal, multi-focal or coupled. ventricular tachycardia. norpace is equally effective whether or not the patient has had a myocardial infarction and also whether or not the patient is receiving digitalis. norpace should only be administered to patients with congestive heart failure when the condition is adequately controlled. norpace should generally be prescribed only after appropiate electrocardiopgraphic assessment. indications for: singapore & hong kong, ventricular arrhythmia as well as ventricular extrasystoles and ventricular tachycar

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - diphenhydramine hydrochloride, quantity: 1 mg/ml; dextromethorphan hydrobromide monohydrate, quantity: 1.25 mg/ml; ephedrine hydrochloride, quantity: 1.5 mg/ml; guaifenesin, quantity: 10 mg/ml - oral liquid - excipient ingredients: sucrose; dibasic sodium phosphate heptahydrate; sorbitol solution; glycerol; sunset yellow fcf; purified water; flavour - indications for: singapore relieves coughing, decongests nasal passages and loosens upper chest congestion due to colds, flu and bronchitis. indications for: hong kong cough suppressant.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - haloperidol, quantity: 2 mg/ml - solution - excipient ingredients: lactic acid; methyl hydroxybenzoate; propyl hydroxybenzoate; purified water - anti psychotic